Cargando…
Applications for Induced Pluripotent Stem Cells in Disease Modelling and Drug Development for Heart Diseases
Induced pluripotent stem cells (iPSCs) are derived from reprogrammed somatic cells by the introduction of defined transcription factors. They are characterised by a capacity for self-renewal and pluripotency. Human (h)iPSCs are expected to be used extensively for disease modelling, drug screening an...
Autores principales: | Nakao, Shu, Ihara, Dai, Hasegawa, Koji, Kawamura, Teruhisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066852/ https://www.ncbi.nlm.nih.gov/pubmed/32180835 http://dx.doi.org/10.15420/ecr.2019.03 |
Ejemplares similares
-
Development of heart failure in young patients with congenital heart disease: a nation-wide cohort study
por: Gilljam, Thomas, et al.
Publicado: (2019) -
Multimodality imaging in carcinoid heart disease
por: Agha, Ali M, et al.
Publicado: (2019) -
Outcome following heart transplant assessment in adults with congenital heart disease
por: Crossland, David Steven, et al.
Publicado: (2019) -
Acute and Chronic Complications of Rheumatic Heart Disease
por: McLeod, Peter, et al.
Publicado: (2020) -
Pacing-associated cardiomyopathy in adult congenital heart disease
por: Moore, Benjamin M, et al.
Publicado: (2020)